» Articles » PMID: 20806064

Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal Cord Injury NOD-scid Mouse Model

Overview
Journal PLoS One
Date 2010 Sep 1
PMID 20806064
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Traumatic spinal cord injury (SCI) results in partial or complete paralysis and is characterized by a loss of neurons and oligodendrocytes, axonal injury, and demyelination/dysmyelination of spared axons. Approximately 1,250,000 individuals have chronic SCI in the U.S.; therefore treatment in the chronic stages is highly clinically relevant. Human neural stem cells (hCNS-SCns) were prospectively isolated based on fluorescence-activated cell sorting for a CD133(+) and CD24(-/lo) population from fetal brain, grown as neurospheres, and lineage restricted to generate neurons, oligodendrocytes and astrocytes. hCNS-SCns have recently been transplanted sub-acutely following spinal cord injury and found to promote improved locomotor recovery. We tested the ability of hCNS-SCns transplanted 30 days post SCI to survive, differentiate, migrate, and promote improved locomotor recovery.

Methods And Findings: hCNS-SCns were transplanted into immunodeficient NOD-scid mice 30 days post spinal cord contusion injury. hCNS-SCns transplanted mice demonstrated significantly improved locomotor recovery compared to vehicle controls using open field locomotor testing and CatWalk gait analysis. Transplanted hCNS-SCns exhibited long-term engraftment, migration, limited proliferation, and differentiation predominantly to oligodendrocytes and neurons. Astrocytic differentiation was rare and mice did not exhibit mechanical allodynia. Furthermore, differentiated hCNS-SCns integrated with the host as demonstrated by co-localization of human cytoplasm with discrete staining for the paranodal marker contactin-associated protein.

Conclusions: The results suggest that hCNS-SCns are capable of surviving, differentiating, and promoting improved locomotor recovery when transplanted into an early chronic injury microenvironment. These data suggest that hCNS-SCns transplantation has efficacy in an early chronic SCI setting and thus expands the "window of opportunity" for intervention.

Citing Articles

Electrical stimulation of the sciatic nerve restores inspiratory diaphragm function in mice after spinal cord injury.

Walling I, Baumgartner S, Patel M, Crone S Front Neural Circuits. 2025; 18:1480291.

PMID: 39911754 PMC: 11794311. DOI: 10.3389/fncir.2024.1480291.


Evaluation of single-dose umbilical cord blood-derived mononuclear cell injection immediately and 7 days after spinal cord trauma in mice.

de Araujo A, Santos G, Marcon R, Nicola M, Pereira M, Sanchez F Clinics (Sao Paulo). 2025; 80:100579.

PMID: 39889361 PMC: 11833352. DOI: 10.1016/j.clinsp.2025.100579.


Revisiting the unobtrusive role of exogenous stem cells beyond neural circuits replacement in spinal cord injury repair.

Wen R, Long G, He X, Zhang K, Ma W, Shen Y Theranostics. 2025; 15(4):1552-1569.

PMID: 39816688 PMC: 11729559. DOI: 10.7150/thno.103033.


Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps.

Jung J, Jeong J, Ko M, Lee B, Kwon W, Jeon S Korean J Neurotrauma. 2025; 20(4):234-245.

PMID: 39803345 PMC: 11711022. DOI: 10.13004/kjnt.2024.20.e45.


Cell Transplantation for Repair of the Spinal Cord and Prospects for Generating Region-Specific Exogenic Neuronal Cells.

Roman A, Huntemer-Silveira A, Waldron M, Khalid Z, Blake J, Parr A Cell Transplant. 2024; 33():9636897241241998.

PMID: 38590295 PMC: 11005494. DOI: 10.1177/09636897241241998.


References
1.
Fawcett J . Overcoming inhibition in the damaged spinal cord. J Neurotrauma. 2006; 23(3-4):371-83. DOI: 10.1089/neu.2006.23.371. View

2.
Ogawa D, Okada Y, Nakamura M, Kanemura Y, Okano H, Matsuzaki Y . Evaluation of human fetal neural stem/progenitor cells as a source for cell replacement therapy for neurological disorders: properties and tumorigenicity after long-term in vitro maintenance. J Neurosci Res. 2008; 87(2):307-17. DOI: 10.1002/jnr.21843. View

3.
Prochazka M, Serreze D, Frankel W, Leiter E . NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes. 1992; 41(1):98-106. DOI: 10.2337/diab.41.1.98. View

4.
Blight A . Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull. 1989; 22(1):47-52. DOI: 10.1016/0361-9230(89)90126-3. View

5.
Fraidakis M, Spenger C, Olson L . Partial recovery after treatment of chronic paraplegia in rat. Exp Neurol. 2004; 188(1):33-42. DOI: 10.1016/j.expneurol.2004.01.032. View